Kinara

Articles

View all

September 12, 2025

13 Minute Read

The Mechanics of Pharma M&A: A Q&A With Gilead’s Devang Bhuva

Chase Feiger

September 4, 2025

12 Minute Read

5 Ways AI Will Reshape Pharma Marketing—And 5 Reasons It Will Matter to HCPs

Zach Capetola

August 21, 2025

11 Minute Read

How GPT-5 Will (and Won’t) Change Pharma Marketers’ Lives

Ahmed Elsayyad

August 14, 2025

9 Minute Read

It’s 2025. Women’s Health Still Isn’t a Priority.

Meg Rivera

August 8, 2025

11 Minute Read

Leading with Authenticity in the Rare Disease Space: A Q&A with Ascendis’ Jay Donovan Wu

Chase Feiger

August 1, 2025

15 Minute Read

40 Years on the HIV front lines with ViiV’s ‘Good Troublemaker’ Kimberly Smith

Larry Dobrow

Five Questions

View all

September 10, 2025

Will McMahon, Director, Omnichannel Strategy, AstraZeneca

Will McMahon

August 27, 2025

Derrick Gastineau, Head of Marketing, Currax Pharmaceuticals

Derrick Gastineau

August 13, 2025

Alison Tapia, Digital Innovation and Omnichannel Expert

Alison Tapia

Podcast

View all

August 5, 2025

Trailer | The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences

Devang Bhuva

July 21, 2025

Trailer | Science and Service: Ascendis’ Jay Donovan Wu on Leading with Authenticity in the Rare Disease Space

Jay Donovan Wu

June 4, 2025

Trailer | Breaking Down Barriers: Akari’s CEO on the Future of Cancer Treatment

Abizer Gaslightwala

April 16, 2025

Trailer | Transforming Maternal Mental Health: Sage Therapeutics’ CEO on the Future of Postpartum Depression Treatment

Barry Greene

January 29, 2025

Trailer | Building a First-Tier Pharma Culture: Bruce Cozadd CEO of Jazz Pharmaceuticals

Bruce Cozadd

December 5, 2024

Trailer | From Doctor to Drug Developer: NewAmsterdam Pharma’s CEO on Transforming Patient Care

Dr. Michael Davidson

What is Kinara?

Revolutionizing Diagnostics:

Exact Sciences CEO on What’s Next

Advancing Neurohealth:
Alkermes CEO on Innovation
and Progress

Building a First-Tier Pharma Culture:
Bruce Cozadd CEO
of Jazz Pharmaceuticals

Articles

The Mechanics of Pharma M&A: A Q&A With Gilead’s Devang Bhuva

5 Ways AI Will Reshape Pharma Marketing—And 5 Reasons It Will Matter to HCPs

How GPT-5 Will (and Won’t) Change Pharma Marketers’ Lives

It’s 2025. Women’s Health Still Isn’t a Priority.

Leading with Authenticity in the Rare Disease Space: A Q&A with Ascendis’ Jay Donovan Wu

40 Years on the HIV front lines with ViiV’s ‘Good Troublemaker’ Kimberly Smith

Five Questions

Will McMahon, Director, Omnichannel Strategy, AstraZeneca

Derrick Gastineau, Head of Marketing, Currax Pharmaceuticals

Alison Tapia, Digital Innovation and Omnichannel Expert

Podcast

Trailer | The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences

Trailer | Science and Service: Ascendis’ Jay Donovan Wu on Leading with Authenticity in the Rare Disease Space

Trailer | Breaking Down Barriers: Akari’s CEO on the Future of Cancer Treatment

Trailer | Transforming Maternal Mental Health: Sage Therapeutics’ CEO on the Future of Postpartum Depression Treatment

Trailer | Building a First-Tier Pharma Culture: Bruce Cozadd CEO of Jazz Pharmaceuticals

Trailer | From Doctor to Drug Developer: NewAmsterdam Pharma’s CEO on Transforming Patient Care

Kinara

Social

Sign up to join insightful conversations with key life science executives in our monthly newsletter.